NIVF

NewGenIvf

0.4480 USD
+0.0138
3.18%
At close Dec 6, 4:00 PM EST
After hours
0.4489
+0.0009
0.20%
1 day
3.18%
5 days
35.76%
1 month
-38.71%
3 months
-34.21%
6 months
-62.35%
Year to date
-70.13%
1 year
-70.13%
5 years
-70.13%
10 years
-70.13%
 

About: NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.

Employees: 70

0
Funds holding %
of 6,794 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

40% more funds holding

Funds holding: 5 [Q2] → 7 (+2) [Q3]

0.08% more ownership

Funds ownership: 1.28% [Q2] → 1.36% (+0.08%) [Q3]

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

26% less capital invested

Capital invested by funds: $128K [Q2] → $94.3K (-$33.4K) [Q3]

Research analyst outlook

We haven’t received any recent analyst ratings for NIVF.

Financial journalist opinion

Neutral
GlobeNewsWire
2 weeks ago
NewGenIvf Receives Nasdaq Delisting Notice and Plans to Submit Appeal, Announces Strategic Path Forward to Regain Compliance
Multiple strategic initiatives include applying to transfer to Nasdaq Capital Market, leveraging recent fundraising arrangements to boost equity Multiple strategic initiatives include applying to transfer to Nasdaq Capital Market, leveraging recent fundraising arrangements to boost equity
NewGenIvf Receives Nasdaq Delisting Notice and Plans to Submit Appeal, Announces Strategic Path Forward to Regain Compliance
Neutral
GlobeNewsWire
1 month ago
NewGenIvf Receives Nasdaq Notification Regarding Minimum Bid Price
BANGKOK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), today announced that on October 8, 2024, the Company received a letter (the “Deficiency Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is currently not in compliance with the closing bid price requirement under Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Rule”).
NewGenIvf Receives Nasdaq Notification Regarding Minimum Bid Price
Neutral
GlobeNewsWire
3 months ago
NewGenIvf Announces Filing of 2023 Annual Report with the SEC
Total Revenues Reach US$5.1 Million Gross Profit Increases by 9.4% to US$1.7 Million Net Income of US$0.1 million
NewGenIvf Announces Filing of 2023 Annual Report with the SEC
Neutral
GlobeNewsWire
4 months ago
NewGenIvf Provides Update on Potential Reverse Merger with COVIRIX
BANGKOK, July 24, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced an update on its proposed reverse merger (the “Proposed Transaction”) with pharmaceutical company COVIRIX Medical Pty Ltd ("COVIRIX"). The Company reports steady progress in its due diligence efforts and, contingent upon meeting all regulatory requirements, anticipates completing the Proposed Transaction by the end of August 2024.
NewGenIvf Provides Update on Potential Reverse Merger with COVIRIX
Neutral
GlobeNewsWire
6 months ago
NewGenIvf Receives Nasdaq Notifications Regarding Market Value of Publicly Held Shares and Market Value of Listed Securities
BANGKOK, May 28, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), today announced that on May 24, 2024, the Company received two letters from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is currently not in compliance with certain requirements under the relevant Nasdaq Listing Rules.
NewGenIvf Receives Nasdaq Notifications Regarding Market Value of Publicly Held Shares and Market Value of Listed Securities
Negative
PennyStocks
7 months ago
3 Obstacles Investors Face When Buying Penny Stocks
Penny stocks represent a unique opportunity for investors aiming to expand their portfolios without a significant initial investment. Trading penny stocks can yield high returns due to their low purchase price, making them an appealing option for both seasoned traders and newcomers to the stock market.
3 Obstacles Investors Face When Buying Penny Stocks
Positive
InvestorPlace
7 months ago
Why Is NewGenIvf (NIVF) Stock Up 60% Today?
Investors in NewGenIvf (NASDAQ: NIVF ) certainly have plenty to cheer today. Shares of NIVF stock were up over 60% in early afternoon trading and more than 100% at one point during today's session.
Why Is NewGenIvf (NIVF) Stock Up 60% Today?
Neutral
GlobeNewsWire
7 months ago
NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with European Wellness Investment Holdings
BANGKOK, Thailand, April 22, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced the execution of a non-binding term sheet (the "Term Sheet") regarding a proposed reverse merger (the “Proposed Transaction”) with healthcare company European Wellness Investment Holdings Limited ("EWIHL").
NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with European Wellness Investment Holdings
Charts implemented using Lightweight Charts™